Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark A Socinski, MD
University of North Carolina, Chapel Hill
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Columbian Hospital
New Westminster, British Columbia, Canada
- William Osler Health Centre, Brampton Clinic
Brampton, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto East General Hospital
Toronto, Ontario, Canada
- Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
- Mcgill University- Dept. of Oncology
Montreal, Quebec, Canada
- Clearview Cancer Institute Oncology Specialties, P.C.
Huntsville, Alabama, United States
- Genesis Cancer Center- Hot Springs
Hot Springs, Arkansas, United States
- Little Rock Hematology Oncology Associates
Little Rock, Arkansas, United States
- Pacific Cancer Medical Center, Inc.
Anaheim, California, United States
- Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- Southwest Cancer Care
Escondido, California, United States
- Robert A. Moss, Md, Facp, Inc.
Fountain Valley, California, United States
- Pacific Shores Medical Group
Long Beach, California, United States
- Ventura County Hematology-Oncology Specialists
Oxnard, California, United States
- Comprehensice Cancer Ctr.
Palms Springs, California, United States
- Gulf Coast Oncology Associates
St. Petersburg, Florida, United States
- Lake County Oncology and Hematology, Pa
Tavares, Florida, United States
- Phoebe Cancer Center
Albany, Georgia, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Kentuckiana Cancer Institute, Pllc
Louisville, Kentucky, United States
- Mercy Hospital
Portland, Maine, United States
- Maine Center for Cancer Medicine
Scarborough, Maine, United States
- Mercy Medical Center
Baltimore, Maryland, United States
- St. Louis University
St Louis, Missouri, United States
- Essex Oncology of North Jersey
Belleville, New Jersey, United States
- Mary Imogene Bassett Hospital
Cooperstown, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- St. Mary Medical Center- Oncology, Hematology Pc
Langhorne, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Dallas Oncology Consultants, Pa
Duncanville, Texas, United States
- the Center for Cancers and Blood Disorders
Fort Worth, Texas, United States
- Joe Arrington Cancer Research and Treatment Center
Lubbock, Texas, United States
- Blood and Cancer Center of East Texas
Tyler, Texas, United States
- Tyler Hematology Oncology
Tyler, Texas, United States
- Fletcher Allen Health Care
Burlington, Vermont, United States
- Cancer Outreach Associates, Pc
Abingdon, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2007
- Primary completion
- 1 Oct 2009
- Completion
- 1 Feb 2013
- Last update posted
- 29 Oct 2019
- Registered enrollment
- 1,052
- Registry id
- NCT00540514
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.